Looks like you’re in the Netherlands, perhaps you’d like to Switch to Global (EN)

About Us

Leader Biomedical is committed to extending the reach of patients and caregivers worldwide. We do this by marketing and distributing medical devices, developing new technologies, and delivering world-class contract manufacturing. Our corporate portfolio consists of synthetic bone substitutes and allografts, hip implants, bone and spine cements, as well as an adhesion control barrier gel and a Hyaluronic Acid gel.

Our purpose

Contributing to the betterment of the global healthcare community with proven solutions and continuous innovation


Our promise

Extending the reach of patients and caregivers by improving global access to reliable, targeted therapeutic solutions and new technologies


Prof. Lugee Li is the founder and sole shareholder of Leader Biomedical Group. Originally a materials engineer, Prof. Lugee Li is the Founder and Chairman of Dongguan Eontec, a new materials and light alloy developer and manufacturer listed on the Shenzhen Stock exchange. In 2016, he acquired a majority interest in Liquidmetal Technologies, the leading developer of bulk amorphous alloys, also known as liquid metal or metallic glass. Prof. Lugee Li currently heads the Chinese Medical Magnesium Alloy Innovation Alliance; it is this initiative that inspired his entry into the field of medical devices.

<strong>2014: Acquisition of EMCM and formation of Leader Biomedical Group</strong>
Subsequent to the acquisition of EMCM, Leader Biomedical Group was formed with headquarters in Amsterdam, the Netherlands to support the future growth and strategy of the business.<strong> </strong>

<strong>2015: Establishment of LB Brazil and LB India</strong>
Leader Biomedical extended its reach with the establishment of Leader Biomedical Brazil in Sao Paulo to bring its line of bone cements to this region and Leader Biomedical India in Bangalore to improve the country’s access to Total Hip and Knee Arthroplasty products.

<strong>2016: Further increase of Leader Biomedical Group’s global reach</strong>
In its pursuit to improving global access to innovative bone graft substitutes and extending the reach of patients and caregivers, Leader Biomedical Group partners with BioTiss in Wels, Austria in a new eCOO<sup>®</sup> Technology manufacturing venture and establishes two more regional ventures with Leader Biomedical RUS in Moscow, Russian Federation and Leader Biomedical APAC in Selangor, Malaysia.

<strong>2017: Expansion into United States</strong>
In our commitment to further increase our downstream value chain and support our vision to continuously improve global access to next generation healthcare, Leader Biomedical Group establishes a venture with Leader Biomedical USA LLC in Schaumburg, USA, starting with the introduction of our synthetic bone substitutes line OssGro® and our patented eCOO® Technology.

<strong>2018: Expansion into Germany</strong>
Leader Biomedical enters into a strategic partnership with International Orthopeadics in Geisingen, Germany to bring our full orthopaedics solutions to this region.

Our ventures

Leader Biomedical office locations can be found in Europe, India, Malaysia, Russia, Brazil, and the US.